Dr. Teri Longacre, MD
Pleasanton, CA
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Longacre, Anatomic Pathologist & Clinical Pathologist in Pleasanton, CA?
Dr. Teri Longacre, MD is an Anatomic Pathologist & Clinical Pathologist, who primarily practices in Pleasanton, CA with 1 additional practice location. She is board certified. Dr. Longacre graduated from University of New Mexico School of Medicine and completed her residency at Stanford Univ Hosp, Anatomic And Clinical Pathology; Univ Of Nm Sch Of Med, Anatomic And Clinical Pathology. Dr. Longacre is fluent in English and Spanish, and is currently seeing new patients. Dr. Longacre’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Longacre’s office at (650) 723-4000.
Where did Dr. Longacre go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Anatomic And Clinical Pathology; Univ Of Nm Sch Of Med, Anatomic And Clinical Pathology | Stanford University Program
Medical School: University of Nm Sch of Med, Albuquerque Nm | University of New Mexico School of Medicine
Is Dr. Longacre board certified as an Anatomic Pathologist & Clinical Pathologist?
Yes, Dr. Teri Longacre, MD is board certified by the American Board of Pathology
What languages does Dr. Longacre speak?
Dr. Longacre and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does an Anatomic Pathologist & Clinical Pathologist like Dr. Longacre typically treat?
As an Anatomic Pathologist & Clinical Pathologist, Dr. Longacre diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Longacre. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Benign Ascending Colon Polyp
- Benign Transverse Colon Polyp
- Benign Cecum Polyp
- Benign Colon Polyp
- Benign Tumor
- Colonic Polyps
- Colon Polyps
- Colonic Disease
- Non-cancerous ascending colon growth
- Ascending colon adenoma
- Ascending colon benign tumor
- Non-cancerous transverse colon growth
- Transverse colon adenoma
- Transverse colon benign tumor
- Non-cancerous cecum growth
- Cecal adenoma
- Cecum benign tumor
- Non-cancerous colon growth
- Colon adenoma
- Benign colon tumor
ICD-10 Codes:
- D122: Benign neoplasm of ascending colon
- D123: Benign neoplasm of transverse colon
- D120: Benign neoplasm of cecum
- D126: Benign neoplasm of colon, unspecified
Also known as:
- Endometrial Cancer
- Uterine Cancer
- Endometrial Cancer Treatment (PDQ®)
- Malignant Endometrial Tumor
- Endometrial Carcinoma
- Cancer of the Endometrium
ICD-10 Codes:
- C541: Malignant neoplasm of endometrium
Also known as:
- Colon Polyps
- Colonic Polyps
- Colorectal polyps
- Bowel polyps
- Intestinal polyps
ICD-10 Codes:
- K635: Polyp of colon
Also known as:
- Chronic Stomach Inflammation
- Stomach Disorder
- Gastritis & Gastropathy
- Chronic gastritis
- Long-term stomach inflammation
- Persistent stomach lining inflammation
ICD-10 Codes:
- K2950: Unspecified chronic gastritis without bleeding
Also known as:
- Other Intestinal Condition
- Colonic Disease
- Small Intestine Disorder
- Bowel Conditions
- Gut Problems
- Digestive Issues
ICD-10 Codes:
- K6389: Other specified diseases of intestine
What procedures does an Anatomic Pathologist & Clinical Pathologist like Dr. Longacre typically perform?
As an Anatomic Pathologist & Clinical Pathologist, procedures performed by Dr. Teri Longacre may include:
- Ancillary Testing
- Blood Sample
- Blood Smear
- Blood Sugar / Plasma Glucose Test
- Bone Pathology
- Chemical Pathology Consultation
- Chemical Pathology Follow Up
- Electrolyte Test / PH Imbalance
Please contact Dr. Longacre's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Longacre accept my insurance?
Dr. Longacre accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Longacre accept in Pleasanton, CA?
Dr. Longacre in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
AllCare Health
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Longacre's office located?
Dr. Teri Longacre's Primary Practice
5555 W Las Positas Blvd
Pleasanton, CA 94588
(650) 723-4000
Recognitions
Publications
Gastrointestil stromal tumor: an unusual cause of gastrointestil bleeding.
, 2013
p16 Is Superior to ProEx C in Identifying High-grade Squamous Intraepithelial Lesions
, 2013
Cell Cycle Regulatory Markers in Uterine Atypical Leiomyoma
, 2013
Atypical Leiomyomas of the Uterus A Clinicopathologic Study of 51 Cases
, 2013
Ovarian Surface Epithelial Neoplasms in the Pediatric Population Incidence, Histologic Subtype
, 2013
Hereditary gyecological maligncies: advances in screening and treatment
, 2013
Hormone-receptor expression and ovarian cancer survival
, 2013
Laboratory-Developed L1 Sequencing and Type-Specific
, 2013
Clear Cell Carcinoma of the Female Genital Tract (Not Everything Is as Clear as it Seems)
, 2012
Are Women With Endocervical Adenocarcinoma at Risk for Lynch Syndrome? Evaluation of 101 C
, 2012
Prediction of BRCA1 Germline Mutation Status in Women With Ovarian Cancer Using Morphology
, 2012
Endometriosis Does Not Confer Improved Prognosis in Ovarian Carcinoma of Uniform Cell Type
, 2012
Myometrial xanthomatosis: possible relationship to prior pregncy procedure.
, 2012
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers
, 2012
A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
, 2011
A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal
, 2011
Low-grade Mucinous Adenocarcinoma of the Uterine Corpus
, 2011
Endocervical Fibroblastic Malignt Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
, 2011
Hepatic Epithelioid Hemangioendothelioma
, 2011
Endometrial hyperplasia
, 2010
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
, 2010
A Panel of 3 Markers Including p16, ProExC
, 2010
Transplantation directs oocyte maturation from embryonic stem cells
, 2009
Appendiceal Mucinous Neoplasms Clinicopathologic Study of 116 Cases With Alysis of Factors
, 2009
Adenomatoid tumors of the female and male genital tracts
, 2009
Massive Extra-adrel Retroperitoneal Paraganglioma: Pre-operative Embolization and Resection
, 2009
Utility of Microtubule Associated Protein-2
, 2009
Expression of the Urothelial Differentiation Markers GATA3 and Placental S100
, 2009
Diagnostic problems in al pathology
, 2008
Mixed ovarian epithelial carcinomas with clear cell
, 2008
Microsatellite instability
, 2008
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)
, 2008
Ovarian mature teratomas with mucinous epithelial neoplasms
, 2008
Emi1 protein accumulation implicates misregulation of the aphase promoting complex
, 2008
Low-grade mucinous epithelial neoplasm
, 2008
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary
, 2008
Ovarian clear cell carcinoma with papillary features
, 2008
Estrogen receptor-negative invasive breast cancer
, 2008
Lymphatic vascular invasion in ovarian serous tumors of low malignt potential with stromal
, 2008
Recommendations for the reporting of fallopian tube neoplasms
, 2007
CDH1 truncating mutations in the E-cadherin gene
, 2007
Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum
, 2007
Recommendations for the reporting of fallopian tube neoplasms
, 2007
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology
, 2007
Pseudomyxoma peritonei syndrome: classification of appendiceal mucinous tumours.
, 2007
p16(INK4A) immunohistochemistry is superior to HPV in situ hybridization for the detection of high
, 2007
Outcomes of women with metachronous breast and ovarian carcinomas
, 2006
Patterns of stromal invasion in ovarian serous tumors of low malignt potential (borderline tumors)
, 2006
Lymph node involvement in ovarian serous tumors of low malignt potential
, 2006
Uterine papillary serous
, 2006
Ductal carcinoma in situ of the breast with osteoclast-like giant cells
, 2006
Interobserver agreement and reproducibility in classification of invasive breast carcinoma
, 2006
Amplification of EMSY, a novel oncogene on 11q13
, 2006
Utility of syndecan-1
, 2005
Appendiceal mucinous tumors and pseudomyxoma peritonei - Histologic features, diagnostic problems
, 2005
Serous tumours of low malignt potential (serous borderline tumours): moving toward detente
, 2005
Characterization of a recurrent germ line mutation of the E-cadherin gene
, 2005
Multinucleated epithelial giant cells in colorectal polyps - A potential mimic of viropathic and
, 2005
Ovarian serous tumors of low malignt potential
, 2005
Distinction between serous tumors of low malignt potential
, 2005
Acute colitis secondary to self-administered alcohol enemas: A mimic of ischemic colitis
, 2005
Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion
, 2005
Serous borderline (low malignt potential, atypical proliferative) ovarian tumors
, 2004
Oviductal glycoprotein
, 2004
Adenomatoid tumors of the female and male genital tracts express WT1
, 2004
Detection of pelvic lymph node micrometastasis in stage IA2
, 2004
Cytomegalovirus infection in steroid-refractory ulcerative colitis - A case-control study
, 2004
Gene expression patterns in ovarian carcinomas
, 2003
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
, 2002
Histological classification of gastric adenocarcinoma for epidemiological research
, 2001
Malignt granular cell tumor of the vulva in a 17-year-old: Case report and literature review.
, 2000
Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements
, 1999
Diffusely infiltrative endometrial adenocarcinoma - An adenoma malignum pattern of myoinvasion
, 1999
Initial experience with a physiologic morcellating resectoscope
, 1998
Chemo-radiotherapy for localized pancreatic cancer
, 1998
Value of inhibin in the identification of granulosa cell tumors of the ovary
, 1997
Bilateral serous cystadenofibrom
, 1997
Multiple mesenteric lymphatic cysts
, 1997
Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma
, 1996
Desmoplastic and spindle-cell malignt melanoma - An immunohistochemical study
, 1996
Adenoid cystic carcinoma of the submandibular gland with symptomatic ovarian metastases
, 1996
Atypical polypoid adenomyofibroma
, 1996
Transitiol cell neoplasms of the ovary and uriry bladder: A comparative immunohistochemical alysis
, 1996
Atypical polypoid adenomyofibromas
, 1996
The female genital tract.
, 1996
Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15
, 1995
OVARIAN-CARCINOMA METASTASES TO GASTROINTESTIL
, 1995
ESOPHAGEAL SUBMUCOSAL GLAND DUCT ADENOMA
, 1995
PROPOSED CRITERIA FOR THE DIAGNOSIS OF WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA
, 1995
UTERINE PAPILLARY SEROUS CARCINOMA REVISITED
, 1994
HEMATOGONES IN THE BONE-MARROW OF ADULTS - IMMUNOPHENOTYPIC FEATURES, CLINICAL SETTINGS
, 1994
ATYPICAL FIBROXANTHOMA - MULTIPLE IMMUNOHISTOLOGIC PROFILES
, 1993
LEUKEMIA-CUTIS - ALYSIS OF 50 BIOPSY-PROVEN CASES WITH AN EMPHASIS ON OCCURRENCE IN MYELODYSPLASTIC
, 1993
Well-differentiated serous neoplasms of the ovary.
, 1993
Classification of surface epithelial neoplasms of the ovary.
, 1993
Clinicopathology of malignt surface epithelial neoplasms of the ovary.
, 1993
KI-1 (CD30) EXPRESSION IN DIFFERENTIATION OF LYMPHOMATOID PAPULOSIS FROM ARTHROPOD BITE REACTIONS
, 1992
MIXED HYPERPLASTIC ADENOMATOUS POLYPS SERRATED ADENOMAS - A DISTINCT FORM OF COLORECTAL NEOPLASIA
, 1990
AGGRESSIVE JEJUL LYMPHOMA OF LARGE GRANULAR LYMPHOCYTES - IMMUNOHISTOCHEMICAL, ULTRASTRUCTURAL
, 1990
ATYPICAL CUTANEOUS LYMPHOPROLIFERATIVE DISORDER RESEMBLING MYCOSIS-FUNGOIDES IN AIDS
, 1989
HEMATOGONES - A MULTIPARAMETER ALYSIS OF BONE-MARROW PRECURSOR CELLS
, 1989
A CORRELATIVE MORPHOLOGICAL-STUDY OF HUMAN-BREAST AND ENDOMETRIUM IN THE MENSTRUAL-CYCLE
, 1986
What is Dr. Longacre's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Longacre's National Provider Identifier (NPI) number is 1528120896.
What common questions do patients ask about Dr. Longacre?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Longacre
What is Dr. Teri Longacre's specialty?
Dr. Longacre is a Anatomic Pathologist & Clinical Pathologist near Pleasanton, CA.
What does an Anatomic Pathologist & Clinical Pathologist do?
A pathologist focuses on the causes and nature of diseases, contributing to diagnosis, prognosis, and treatment by applying knowledge from biological, chemical, and physical sciences in the laboratory. They utilize microscopic examinations of tissue specimens, cells, and body fluids, along with clinical laboratory tests on fluids and secretions, to diagnose, exclude, or monitor diseases.
Is this Dr. Teri Longacre affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Longacre is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Anatomic Pathologist & Clinical Pathologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Anatomic Pathologist & Clinical Pathologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Teri Longacre accepting new patients in Pleasanton, CA?
Yes, Dr. Teri Longacre is accepting new patients at this time.
Does Dr. Teri Longacre offer online booking?
Please contact Dr. Longacre's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Teri Longacre?
Please contact Dr. Longacre's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Teri Longacre have?
Dr. Teri Longacre is certified by the American Board of Pathology.
Other Anatomic Pathologist & Clinical Pathologist Near Pleasanton, CA
Anatomic Pathologist & Clinical Pathologist
Accepting patientsAnatomic Pathologist & Clinical Pathologist
Accepting patients
Dermatologist
Accepting patients